Skip to content
GLP-1 Savers
Menu
Ranked #367 · Watch List

Willow review

Willow sells compounded semaglutide and tirzepatide in both weekly injections and under-the-tongue tablets, publishing $299 a month for semaglutide on its own product page.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $299/mo

Save ~78% vs brand-name

From $299/mo (starting dose, compounded)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a starting rate, not a price that is guaranteed at every dose.

How much does Willow cost?

The price Willow publishes is From $299/mo (starting dose, compounded). Tirzepatide is listed at From $399/mo (starting dose, compounded). We flag this one to watch: confirm the ongoing rate with Willow before you count on it, because a low first month can step up afterward. That works out about 78% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $299/mo (starting dose, compounded)
Tirzepatide
From $399/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

The Value Score card

Willow scored on our six published factors. See the methodology.

Lowest Real Price52/100
No Teaser-Rate Bait64/100
Nationwide Availability45/100
Both Molecules98/100
Easy Cancellation58/100
Reputation73/100

Why it's a deal

  • Publishes the semaglutide rate on the product page at $299 a month rather than holding it until after an intake
  • Offers both molecules in tablet form as well as injection, so the needle is optional on either route
  • Runs its own semaglutide-versus-tirzepatide comparison rather than steering every visitor to one product
  • Shipments can be adjusted rather than fixed to a rigid schedule

Read the fine print

  • $299 for semaglutide sits well above the roughly $179 median across the programs tracked here, and the tirzepatide rate is higher again
  • The states it serves are not published anywhere on the site
  • Compounded only — no FDA-approved brand-name option
  • The pharmacy that compounds the medication is not named, and no 503A or 503B designation is given

The bottom line

Best for: Someone who wants a needle-free tablet option from a program that prices it openly. Willow sells compounded semaglutide and tirzepatide in both weekly injections and under-the-tongue tablets, publishing $299 a month for semaglutide on its own product page.

Ranked #367 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Willow, out of 426 others we track.

Shopping Willow against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Willow, and every program that undercuts or outscores it — starting with PrescribedRX, the closest match on score — is ranked on the Willow alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Willow's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Willow's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals